Xlife Sciences AG (XLS) — Financial Flexibility Index
Xlife Sciences AG (XLS) has a Financial Flexibility Index of 0.00x as of June 2025. Free cash flow of CHF-803.62K (operating CF CHF-803.62K minus capex CHF0.00) represents 0% of total liabilities (CHF232.84 Million). Check XLS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xlife Sciences AG Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Xlife Sciences AG across 7 annual periods. For the full cash flow conversion analysis, see Xlife Sciences AG cash conversion from operations.
Annual Financial Flexibility Index for Xlife Sciences AG (2019–2025)
Year-by-year free cash flow to debt coverage for Xlife Sciences AG. Explore cash flow to debt ratio of Xlife Sciences AG to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | CHF-530.80K | CHF-903.00K | CHF144.76 Million | ▼ -110.6% |
| 2024 | 0.00x | CHF-409.42K | CHF-421.51K | CHF235.11 Million | ▼ -299.5% |
| 2023 | 0.00x | CHF212.86K | CHF171.78K | CHF243.82 Million | ▲ +104.9% |
| 2022 | -0.02x | CHF-4.53 Million | CHF-4.61 Million | CHF255.00 Million | ▼ -53.4% |
| 2021 | -0.01x | CHF-3.11 Million | CHF-4.32 Million | CHF268.83 Million | ▼ -258.3% |
| 2020 | 0.00x | CHF-179.36K | CHF-401.55K | CHF55.51 Million | ▲ +51.0% |
| 2019 | -0.01x | CHF-373.31K | CHF-398.24K | CHF56.64 Million | — |